PortfoliosLab logoPortfoliosLab logo
CNRG vs. CURE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

CNRG vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SPDR S&P Kensho Clean Power ETF (CNRG) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CNRG achieves a 2.01% return, which is significantly lower than CURE's 6.99% return.


CNRG

1D
-0.59%
1M
-13.20%
6M
-6.95%
YTD
2.01%
1Y
40.07%
3Y*
4.32%
5Y*
-0.42%
10Y*
ALL TIME*
17.18%

CURE

1D
-1.72%
1M
-3.56%
6M
9.07%
YTD
6.99%
1Y
68.66%
3Y*
7.13%
5Y*
0.86%
10Y*
13.35%
ALL TIME*
24.24%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$1.13M$1.07M$1.47M
$8.40M$9.61M$9.25M

CNRG vs. CURE - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
CNRG
SPDR S&P Kensho Clean Power ETF
2.01%50.23%-14.48%-11.55%-7.98%-15.68%138.35%63.26%-2.05%
CURE
Direxion Daily Healthcare Bull 3x Shares
6.99%22.55%-8.47%-9.40%-20.51%88.30%5.02%55.66%-16.35%

Correlation

The correlation between CNRG and CURE is 0.00, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.00

Correlation (3Y)
Balances recent behavior with more history.

0.20

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.29

Correlation (All Time)
Calculated using the full available price history since Oct 23, 2018

0.35

Over the past year, the correlation between CNRG and CURE has dropped to 0.00 - well below their long-term average of 0.35, suggesting their price drivers have been diverging.

CNRG vs. CURE - Sectors Allocation Comparison


Sectors
CNRG
CURE

Utilities

35.8%

-

Industrials

31.1%

-

Technology

19.0%
0.1%

Energy

12.0%

-

Consumer Cyclical

2.0%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Defensive

-

-

Financial Services

-

-

Healthcare

-

20.5%

Real Estate

-

-

Utilities

CNRG
35.8%
CURE

-

Industrials

CNRG
31.1%
CURE

-

Technology

CNRG
19.0%
CURE
0.1%

Energy

CNRG
12.0%
CURE

-

Consumer Cyclical

CNRG
2.0%
CURE

-

Basic Materials

CNRG

-

CURE

-

Communication Services

CNRG

-

CURE

-

Consumer Defensive

CNRG

-

CURE

-

Financial Services

CNRG

-

CURE

-

Healthcare

CNRG

-

CURE
20.5%

Real Estate

CNRG

-

CURE

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CNRG vs. CURE — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

CNRG
CNRG Risk / Return Rank: 3737
Overall Rank
CNRG Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
CNRG Sortino Ratio Rank: 3939
Sortino Ratio Rank
CNRG Omega Ratio Rank: 3737
Omega Ratio Rank
CNRG Calmar Ratio Rank: 3636
Calmar Ratio Rank
CNRG Martin Ratio Rank: 3838
Martin Ratio Rank

CURE
CURE Risk / Return Rank: 6363
Overall Rank
CURE Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 7373
Sortino Ratio Rank
CURE Omega Ratio Rank: 6060
Omega Ratio Rank
CURE Calmar Ratio Rank: 6666
Calmar Ratio Rank
CURE Martin Ratio Rank: 4646
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

CNRG vs. CURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Kensho Clean Power ETF (CNRG) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CNRGCUREDifference
Sharpe ratioReturn per unit of total volatility

-0.61

Sortino ratioReturn per unit of downside risk

-0.89

Omega ratioGain probability vs. loss probability

1.17

1.26

-0.08

Calmar ratioReturn relative to maximum drawdown

1.21

2.31

-1.11

Martin ratioReturn relative to average drawdown

3.76

5.20

-1.44

CNRG vs. CURE - Sharpe Ratio Comparison

The current CNRG Sharpe Ratio is 0.95, which is lower than the CURE Sharpe Ratio of 1.56. The chart below compares the historical Sharpe Ratios of CNRG and CURE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CNRG vs. CURE - Drawdown Comparison

The maximum CNRG drawdown since its inception was -68.49%, roughly equal to the maximum CURE drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for CNRG and CURE.


Loading charts...

Drawdown Indicators


CNRGCUREDifference

Max Drawdown

Largest peak-to-trough decline

-68.49%

-69.19%

+0.70%

Max Drawdown (1Y)

Largest decline over 1 year

-31.56%

-31.10%

-0.46%

Max Drawdown (3Y)

Largest decline over 3 years

-43.59%

-51.93%

+8.34%

Max Drawdown (5Y)

Largest decline over 5 years

-59.17%

-52.23%

-6.94%

Max Drawdown (10Y)

Largest decline over 10 years

-69.19%

Current Drawdown

Current decline from peak

-33.66%

-15.08%

-18.58%

Average Drawdown

Average peak-to-trough decline

-31.66%

-18.17%

-13.49%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.11%

13.82%

-3.71%

Volatility

CNRG vs. CURE - Volatility Comparison

The current volatility for SPDR S&P Kensho Clean Power ETF (CNRG) is 13.34%, while Direxion Daily Healthcare Bull 3x Shares (CURE) has a volatility of 17.62%. This indicates that CNRG experiences smaller price fluctuations and is considered to be less risky than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CNRGCUREDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.34%

17.62%

-4.28%

Volatility (6M)

Calculated over the trailing 6-month period

29.61%

35.23%

-5.62%

Volatility (1Y)

Calculated over the trailing 1-year period

40.16%

46.92%

-6.76%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

34.83%

44.69%

-9.86%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

36.13%

49.85%

-13.72%

CNRG vs. CURE - Expense Ratio Comparison

CNRG has a 0.45% expense ratio, which is lower than CURE's 0.94% expense ratio.


Dividends

CNRG vs. CURE - Dividend Comparison

CNRG's dividend yield for the trailing twelve months is around 1.34%, more than CURE's 1.06% yield.


PositionTTM202520242023202220212020201920182017
CNRG
SPDR S&P Kensho Clean Power ETF
1.34%1.46%1.34%1.17%1.23%1.34%0.69%1.16%0.35%0.00%
CURE
Direxion Daily Healthcare Bull 3x Shares
1.06%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%

Frequently Asked Questions


CNRG and CURE have a correlation of 0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CURE has higher volatility (17.62%) compared to CNRG (13.34%). In terms of maximum drawdown, CNRG dropped -68.49% vs CURE's -69.19%.

On 5-year performance, CURE leads with 0.86% vs -0.42% for CNRG. On fees, CNRG is cheaper at 0.45% per year. On volatility, CNRG has been the lower-risk option at 13.34%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, CURE has performed better with a 0.86% return vs -0.42%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

CNRG is cheaper with a 0.45% expense ratio, compared with 0.94% for CURE.

CNRG has the higher dividend yield at 1.34%, compared with 1.06% for CURE.

CNRG is categorized as Alternative Energy Equities, while CURE is Leveraged Equities. CNRG tracks S&P Kensho Clean Power Index, while CURE tracks Health Care Select Sector Index (300%). They also come from different issuers: State Street and Direxion. Their fees differ too: 0.45% for CNRG and 0.94% for CURE.

CURE currently has the higher Sharpe Ratio (1.56 vs 0.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CNRG and CURE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer